Mexico - Delayed Quote MXN

Novavax, Inc. (NVAX.MX)

Compare
185.00
+1.00
+(0.54%)
At close: January 30 at 2:55:23 PM CST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
847,250.00
556,382.00
1,598,951.00
197,581.00
22,388.00
Cost of Revenue
321,046.00
343,768.00
902,639.00
--
--
Gross Profit
526,204.00
212,614.00
696,312.00
197,581.00
22,388.00
Operating Expense
827,623.00
779,125.00
1,341,048.00
1,884,157.00
439,107.00
Operating Income
-301,419.00
-566,511.00
-644,736.00
-1,686,576.00
-416,719.00
Net Non Operating Interest Income Expense
-16,607.00
-14,416.00
-19,880.00
-21,127.00
-15,145.00
Other Income Expense
38,291.00
37,896.00
10,969.00
-6,833.00
13,605.00
Pretax Income
-279,735.00
-543,031.00
-653,647.00
-1,714,536.00
-418,259.00
Tax Provision
5,123.00
2,031.00
4,292.00
29,215.00
--
Net Income Common Stockholders
-284,858.00
-545,062.00
-657,939.00
-1,743,751.00
-418,259.00
Diluted NI Available to Com Stockholders
-284,858.00
-545,062.00
-657,939.00
-1,743,751.00
-418,259.00
Basic EPS
-2.18
-5.41
-8.42
-23.44
-7.27
Diluted EPS
-2.18
-5.41
-8.42
-23.44
-7.27
Basic Average Shares
143,098.00
100,768.00
78,183.00
74,400.00
57,554.00
Diluted Average Shares
143,098.00
100,768.00
78,183.00
74,400.00
57,554.00
Total Operating Income as Reported
-301,419.00
-566,511.00
-644,736.00
-1,686,576.00
-416,719.00
Total Expenses
1,148,669.00
1,122,893.00
2,243,687.00
1,884,157.00
439,107.00
Net Income from Continuing & Discontinued Operation
-284,858.00
-545,062.00
-657,939.00
-1,743,751.00
-418,259.00
Normalized Income
-284,858.00
-545,062.00
-657,939.00
-1,743,751.00
-418,259.00
Interest Expense
16,607.00
14,416.00
19,880.00
21,127.00
15,145.00
Net Interest Income
-16,607.00
-14,416.00
-19,880.00
-21,127.00
-15,145.00
EBIT
-263,128.00
-528,615.00
-633,767.00
-1,693,409.00
-403,114.00
EBITDA
-216,355.00
-487,390.00
-604,713.00
-1,680,748.00
-398,229.00
Reconciled Cost of Revenue
321,046.00
343,768.00
902,639.00
--
--
Reconciled Depreciation
46,773.00
41,225.00
29,054.00
12,661.00
4,885.00
Net Income from Continuing Operation Net Minority Interest
-284,858.00
-545,062.00
-657,939.00
-1,743,751.00
-418,259.00
Total Unusual Items Excluding Goodwill
--
--
--
1,364.00
1,014.00
Total Unusual Items
--
--
--
1,364.00
1,014.00
Normalized EBITDA
-216,355.00
-487,390.00
-604,713.00
-1,680,748.00
-398,229.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
--
12/31/2020 - 7/14/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MDG1.HM Medigene AG
1.7400
-7.45%
 
HDP1.DU Arrowhead Pharmaceuticals Inc
19.45
+1.57%
 
AYJ.F Valneva SE
2.4880
+3.84%
 
MDG1.DE Medigene AG
1.7500
-2.78%
 
IFRX InflaRx N.V.
2.3700
+5.80%
 
AFMD Affimed N.V.
0.9794
-2.06%
 
FBIO Fortress Biotech, Inc.
1.7800
+2.30%
 
CVAC CureVac N.V.
3.8200
-1.29%
 
ARGX argenx SE
665.68
+1.67%
 
XFOR X4 Pharmaceuticals, Inc.
0.6621
-9.94%